Skip to main content
Top
Published in: PharmacoEconomics 2/2003

01-02-2003 | Review Article

Cost of Illness of Atopic Dermatitis in Children

A Societal Perspective

Author: Professor Andrew S. Kemp

Published in: PharmacoEconomics | Issue 2/2003

Login to get access

Abstract

Childhood atopic dermatitis is a disorder with considerable social and financial costs. Consideration of these costs is increasingly important in view of the growing prevalence of atopic dermatitis, particularly in developed countries over recent decades. The family stress related to the care of children with moderate or severe atopic dermatitis is significantly greater than that of the care of children with type 1 diabetes mellitus. The factors contributing to family stress include sleep deprivation, loss of employment, time taken for care of atopic dermatitis and financial costs. The financial costs for the family and community include medical and hospital direct costs of treatments and indirect costs from loss of employment. There are many interventions utilised in the treatment of childhood atopic dermatitis which involve not only medical practitioners but nurses, pharmacists, dieticians, psychologists and purveyors of so-called alternative therapies such as naturopathy, aromatherapy and bioresonance, all of which contribute to the financial burdens on the parents and the community. It is possible that appropriate interventions directed to reducing trigger factors might produce worthwhile savings, although the cost benefit of these measures has not been demonstrated. In conclusion, atopic dermatitis should not be regarded as a minor skin disorder but as a condition which has the potential to be a major handicap with considerable personal, social and financial consequences both to the family and the community.
Literature
1.
go back to reference Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351: 1225–32 Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351: 1225–32
2.
go back to reference Castles I. 1989–90 National health survey summary of results. Canberra: Australian Bureau of Statistics, 1991 Castles I. 1989–90 National health survey summary of results. Canberra: Australian Bureau of Statistics, 1991
3.
go back to reference Asher MI, Barry D, Clayton T, et al. The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One. N Z Med J 2001; 114: 114–20PubMed Asher MI, Barry D, Clayton T, et al. The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One. N Z Med J 2001; 114: 114–20PubMed
4.
go back to reference Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 1996; 34: 760–4PubMedCrossRef Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 1996; 34: 760–4PubMedCrossRef
5.
go back to reference Tay YK, Kong KH, Khoo L, et al. The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children. Br J Dermatol 2002; 146: 101–6PubMedCrossRef Tay YK, Kong KH, Khoo L, et al. The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children. Br J Dermatol 2002; 146: 101–6PubMedCrossRef
6.
go back to reference Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993; 28: 719–23PubMedCrossRef Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993; 28: 719–23PubMedCrossRef
7.
go back to reference Butland BK, Strachan DP, Lewis S, et al. Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts. BMJ 1997; 315: 717–21PubMedCrossRef Butland BK, Strachan DP, Lewis S, et al. Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts. BMJ 1997; 315: 717–21PubMedCrossRef
8.
go back to reference Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125–38PubMedCrossRef Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125–38PubMedCrossRef
9.
go back to reference Su JC, Kemp AS, Varigos GA, et al. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997; 76: 159–62PubMedCrossRef Su JC, Kemp AS, Varigos GA, et al. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997; 76: 159–62PubMedCrossRef
10.
go back to reference Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 13–4 Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 13–4
11.
go back to reference Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993; 69: 670–6PubMedCrossRef Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993; 69: 670–6PubMedCrossRef
12.
go back to reference Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998; 138: 107–13PubMedCrossRef Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998; 138: 107–13PubMedCrossRef
13.
go back to reference Reid P, Lewis-Jones MS. Sleep difficulties and their management in preschoolers with atopic eczema. Clin Exp Dermatol 1995; 20: 38–41PubMedCrossRef Reid P, Lewis-Jones MS. Sleep difficulties and their management in preschoolers with atopic eczema. Clin Exp Dermatol 1995; 20: 38–41PubMedCrossRef
14.
go back to reference Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, et al. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995; 149: 856–60PubMedCrossRef Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, et al. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995; 149: 856–60PubMedCrossRef
15.
go back to reference Lewis-Jones MS, Finlay AY, Dykes PJ. The infants’ dermatitis quality of life index. Br J Dermatol 2001; 144: 104–10PubMedCrossRef Lewis-Jones MS, Finlay AY, Dykes PJ. The infants’ dermatitis quality of life index. Br J Dermatol 2001; 144: 104–10PubMedCrossRef
16.
go back to reference Lapidus CS, Kerr PE. Social impact of atopic dermatitis. Med Health R I 2001; 84: 294–5PubMed Lapidus CS, Kerr PE. Social impact of atopic dermatitis. Med Health R I 2001; 84: 294–5PubMed
17.
go back to reference Fennessy M, Coupland S, Popay J, et al. The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research. J Epidemiol Community Health 2000; 54: 581–9PubMedCrossRef Fennessy M, Coupland S, Popay J, et al. The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research. J Epidemiol Community Health 2000; 54: 581–9PubMedCrossRef
18.
go back to reference Stewart AW, Mitchell EA, Pearce N, et al. The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol 2001; 30: 173–9PubMedCrossRef Stewart AW, Mitchell EA, Pearce N, et al. The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol 2001; 30: 173–9PubMedCrossRef
19.
go back to reference Lamb SR, Rademaker M. Pharmacoeconomics of drug therapy for atopic dermatitis. Exp Opin Pharmacother 2002; 3: 249–55CrossRef Lamb SR, Rademaker M. Pharmacoeconomics of drug therapy for atopic dermatitis. Exp Opin Pharmacother 2002; 3: 249–55CrossRef
20.
go back to reference Kernick D, Cox A, Powell R, et al. A cost consequence study of the impact of a dermatology-trained practice nurse on the quality of life of primary care patients with eczema and psoriasis. Br J Gen Pract 2000; 50: 555–8PubMed Kernick D, Cox A, Powell R, et al. A cost consequence study of the impact of a dermatology-trained practice nurse on the quality of life of primary care patients with eczema and psoriasis. Br J Gen Pract 2000; 50: 555–8PubMed
21.
22.
go back to reference Resnick SD, Hornung R, Konrad TR. A comparison of dermatologists and generalists: management of childhood atopic dermatitis. Arch Dermatol 1996; 132: 1047–52PubMedCrossRef Resnick SD, Hornung R, Konrad TR. A comparison of dermatologists and generalists: management of childhood atopic dermatitis. Arch Dermatol 1996; 132: 1047–52PubMedCrossRef
23.
go back to reference Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: who cares? who pays? J Am Acad Dermatol 1993; 28: 699–703PubMedCrossRef Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: who cares? who pays? J Am Acad Dermatol 1993; 28: 699–703PubMedCrossRef
24.
go back to reference Ellis CN, Drake LA, Prendergast MM, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002; 46: 361–70PubMedCrossRef Ellis CN, Drake LA, Prendergast MM, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002; 46: 361–70PubMedCrossRef
25.
26.
go back to reference Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1–191PubMed Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1–191PubMed
27.
go back to reference Khan SN, Slavin RG. Pediatricians’ attitudes towards allergy: past and present attitudes of pediatricians towards allergy. Ann Allergy Asthma Immunol 2000; 85: 189–93PubMedCrossRef Khan SN, Slavin RG. Pediatricians’ attitudes towards allergy: past and present attitudes of pediatricians towards allergy. Ann Allergy Asthma Immunol 2000; 85: 189–93PubMedCrossRef
29.
go back to reference Marks R. The public health approach to the burden of common skin diseases in the community. J Dermatol 2001; 28: 602–5PubMed Marks R. The public health approach to the burden of common skin diseases in the community. J Dermatol 2001; 28: 602–5PubMed
30.
go back to reference Hammarstrom B, Wessling A, Nilsson JL. Pharmaceutical care for patients with skin diseases: a campaign year at Swedish pharmacies. J Clin Pharm Ther 1995; 20: 327–34PubMedCrossRef Hammarstrom B, Wessling A, Nilsson JL. Pharmaceutical care for patients with skin diseases: a campaign year at Swedish pharmacies. J Clin Pharm Ther 1995; 20: 327–34PubMedCrossRef
31.
go back to reference Shum KW, Lawton S, Williams HC, et al. The British Association of Dermatologists audit of atopic eczema management in secondary care. Phase 1: audit of service structure. Br J Dermatol 1999; 141: 430–7PubMedCrossRef Shum KW, Lawton S, Williams HC, et al. The British Association of Dermatologists audit of atopic eczema management in secondary care. Phase 1: audit of service structure. Br J Dermatol 1999; 141: 430–7PubMedCrossRef
32.
go back to reference Chinn DJ, Poyner T, Sibley G. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2002; 146: 432–9PubMedCrossRef Chinn DJ, Poyner T, Sibley G. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2002; 146: 432–9PubMedCrossRef
33.
go back to reference Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema [abstract]. BMJ 2002; 324: 768–71PubMedCrossRef Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema [abstract]. BMJ 2002; 324: 768–71PubMedCrossRef
34.
go back to reference Cheer SM, Plosker GL. Tacrolimus ointment: a review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2001; 2: 389–406PubMedCrossRef Cheer SM, Plosker GL. Tacrolimus ointment: a review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2001; 2: 389–406PubMedCrossRef
35.
go back to reference Wellington K, Jarvis B. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. Drugs 2002; 62: 817–40PubMedCrossRef Wellington K, Jarvis B. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. Drugs 2002; 62: 817–40PubMedCrossRef
36.
go back to reference Reitamo S, Van Leent EJ, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 539–46PubMedCrossRef Reitamo S, Van Leent EJ, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 539–46PubMedCrossRef
37.
go back to reference Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002; 46: 228–41PubMedCrossRef Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002; 46: 228–41PubMedCrossRef
38.
go back to reference Wahn U, Bos JD, Goodfield M, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children [online]. Pediatrics 2002; 110: e2PubMedCrossRef Wahn U, Bos JD, Goodfield M, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children [online]. Pediatrics 2002; 110: e2PubMedCrossRef
39.
go back to reference Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993; 129: 422–30PubMedCrossRef Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993; 129: 422–30PubMedCrossRef
40.
go back to reference Jang IG, Yang JK, Lee HJ, et al. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma. J Am Acad Dermatol 2000; 42: 1033–40PubMedCrossRef Jang IG, Yang JK, Lee HJ, et al. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma. J Am Acad Dermatol 2000; 42: 1033–40PubMedCrossRef
41.
go back to reference Jolles S, Hughes J, Rustin M. The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature. Br J Dermatol 2000; 142: 551–4PubMedCrossRef Jolles S, Hughes J, Rustin M. The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature. Br J Dermatol 2000; 142: 551–4PubMedCrossRef
42.
43.
go back to reference Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol 1990; 70: 421–4PubMed Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol 1990; 70: 421–4PubMed
44.
go back to reference Ashcroft DM, Po AL. Herbal remedies: issues in licensing and economic evaluation. Pharmacoeconomics 1999; 16 (4): 321–8PubMedCrossRef Ashcroft DM, Po AL. Herbal remedies: issues in licensing and economic evaluation. Pharmacoeconomics 1999; 16 (4): 321–8PubMedCrossRef
45.
go back to reference Fung AY, Look PC, Chong LY, et al. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999; 38: 387–92PubMedCrossRef Fung AY, Look PC, Chong LY, et al. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999; 38: 387–92PubMedCrossRef
46.
go back to reference Worm M, Henz BM. Novel unconventional therapeutic approaches to atopic eczema. Dermatology 2000; 201: 191–5PubMedCrossRef Worm M, Henz BM. Novel unconventional therapeutic approaches to atopic eczema. Dermatology 2000; 201: 191–5PubMedCrossRef
47.
go back to reference Ohya Y, Williams H, Steptoe A, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 2001; 117: 852–7PubMedCrossRef Ohya Y, Williams H, Steptoe A, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 2001; 117: 852–7PubMedCrossRef
48.
go back to reference Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142: 931–6PubMedCrossRef Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142: 931–6PubMedCrossRef
49.
go back to reference Poysa L, Remes K, Korppi M, et al. Compliance with a dietary manipulation programme in families with infants prone to atopy. Acta Paediatr Scand 1988; 77: 563–8PubMedCrossRef Poysa L, Remes K, Korppi M, et al. Compliance with a dietary manipulation programme in families with infants prone to atopy. Acta Paediatr Scand 1988; 77: 563–8PubMedCrossRef
50.
go back to reference Chandra RK. Five-year follow-up of high-risk infants with family history of allergy who were exclusively breast-fed or fed partial whey hydrolysate, soy, and conventional cow’s milk formulas. J Pediatr Gastroenterol Nutr 1997; 24: 380–8PubMedCrossRef Chandra RK. Five-year follow-up of high-risk infants with family history of allergy who were exclusively breast-fed or fed partial whey hydrolysate, soy, and conventional cow’s milk formulas. J Pediatr Gastroenterol Nutr 1997; 24: 380–8PubMedCrossRef
51.
go back to reference Halken S, Hansen KS, Jacobsen HP, et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatr Allergy Immunol 2000; 11: 149–61PubMedCrossRef Halken S, Hansen KS, Jacobsen HP, et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatr Allergy Immunol 2000; 11: 149–61PubMedCrossRef
52.
go back to reference Pike MG, Carter CM, Boulton P, et al. Few food diets in the treatment of atopic eczema. Arch Dis Child 1989; 64: 1691–8PubMedCrossRef Pike MG, Carter CM, Boulton P, et al. Few food diets in the treatment of atopic eczema. Arch Dis Child 1989; 64: 1691–8PubMedCrossRef
53.
go back to reference Tan BB, Weald D, Strickland I, et al. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347: 15–8PubMedCrossRef Tan BB, Weald D, Strickland I, et al. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347: 15–8PubMedCrossRef
54.
go back to reference Schiffner R, Schiffner-Rohe J, Gerstenhauer M, et al. Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications. Br J Dermatol 2001; 144: 1154–60PubMedCrossRef Schiffner R, Schiffner-Rohe J, Gerstenhauer M, et al. Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications. Br J Dermatol 2001; 144: 1154–60PubMedCrossRef
Metadata
Title
Cost of Illness of Atopic Dermatitis in Children
A Societal Perspective
Author
Professor Andrew S. Kemp
Publication date
01-02-2003
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 2/2003
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200321020-00003

Other articles of this Issue 2/2003

PharmacoEconomics 2/2003 Go to the issue